1ml of hylan GF 20 contains: hylan 8.0mg, sodium chloride 8.5mg, disodium hydrogenphosphate 0.16mg, sodium triphosphate monohydrate 0.04mg, water for injection qs
The unique Syringe Syringe 16mg / 2ml naturally relieves the daily discomfort associated with degeneration of the joints. The substance that replaces or replaces the synovial fluid is hylan, a hyaluronan derivative that is a natural component of synovial fluid. Hylan is made up of recurring N-acetyl-glucosamine disaccharide units and sodium glucoronate. It is characterized by better parameters than hyaluronan, so its use in the preparation helps to fight the pain for a long time. Moreover, it spreads in a completely safe way, just like hyaluronan. The product works on the principle of visibility, ie it restores the physiological and rheological state of the tissues. The Synvisc medical device is best for treating pain and increasing the mobility of the knee joint.
Synvisc 16mg / 2ml medical device intended for use in the periodic replacement and supplementation of synovial fluid for the treatment of pain associated with osteoarthritis and to improve joint mobility by reducing or eliminating pain, especially in patients with advanced degenerative joint disease. .
Synvisc Additional Information:
Keep out of the reach of children at room temperature (2 ° C-30 ° C). Do not freeze. Do not administer intravascular or extracranial. Prior to application, do not use disinfectants with quaternary ammonium salts.
Undesirable effects Synvisc:
Synvisc 16mg / 2ml may cause side effects: pain, heat, swelling and / or exudate in the joint area. Usually, these symptoms are stronger at the first injection and disappear after some time.
Do not use in case of hypersensitivity to any of the ingredients. It should not be used in patients with venous stasis or lymphatic stasis. Do not use in case of severe arthritis, knee infection, skin diseases, infections at the injection site.
How to use:
The dose and frequency is determined by the doctor. One injection is recommended for the knee joint. The activity can be repeated after 6 months, depending on the individual symptoms of the patient.